These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29398278)

  • 21. Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked.
    Koch C; Engele J
    Mol Pharmacol; 2020 Nov; 98(5):577-585. PubMed ID: 32883765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CXCR4 as a rheostat of humoral response].
    Khamyath M; Bonaud A; Balabanian K; Espéli M
    Med Sci (Paris); 2023 Jan; 39(1):23-30. PubMed ID: 36692314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneurons.
    Abe P; Mueller W; Schütz D; MacKay F; Thelen M; Zhang P; Stumm R
    Development; 2014 May; 141(9):1857-63. PubMed ID: 24718993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors.
    Gómez-Moutón C; Fischer T; Peregil RM; Jiménez-Baranda S; Stossel TP; Nakamura F; Mañes S
    Blood; 2015 Feb; 125(7):1116-25. PubMed ID: 25355818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets.
    Puchert M; Engele J
    Cell Tissue Res; 2014 Feb; 355(2):239-53. PubMed ID: 24292718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritis.
    Brunn A; Utermöhlen O; Mihelcic M; Sánchez-Ruiz M; Carstov M; Blau T; Ustinova I; Penfold M; Montesinos-Rongen M; Deckert M
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):772-87. PubMed ID: 23452257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptive Immunodeficiency in WHIM Syndrome.
    Majumdar S; Murphy PM
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological roles of the homeostatic chemokine CXCL12.
    Janssens R; Struyf S; Proost P
    Cytokine Growth Factor Rev; 2018 Dec; 44():51-68. PubMed ID: 30396776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
    Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T
    FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dysfunctions of the CXCL12 (SDF-1)/CXCR4 signaling axis in the WHIM syndrome and the idiopathic CD4(+) T-cell lymphocytopenia].
    Biajoux V; Bignon A; Bouchet-Delbos L; Emilie D; Balabanian K
    Biol Aujourdhui; 2010; 204(4):273-84. PubMed ID: 21215244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma.
    Rusetska N; Kowalski K; Zalewski K; Zięba S; Bidziński M; Goryca K; Kotowicz B; Fuksiewicz M; Kopczynski J; Bakuła-Zalewska E; Kowalik A; Kowalewska M
    J Clin Pathol; 2022 May; 75(5):324-332. PubMed ID: 33692092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells.
    Neves M; Marolda V; Mayor F; Penela P
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.
    Cheng YH; Eby JM; LaPorte HM; Volkman BF; Majetschak M
    PLoS One; 2017; 12(11):e0187949. PubMed ID: 29125867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebellar involvement in warts Hypogammaglobulinemia immunodeficiency myelokathexis patients: neuroimaging and clinical findings.
    Galli J; Pinelli L; Micheletti S; Palumbo G; Notarangelo LD; Lougaris V; Dotta L; Fazzi E; Badolato R
    Orphanet J Rare Dis; 2019 Feb; 14(1):61. PubMed ID: 30819232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCR4 mutations in WHIM syndrome: a misguided immune system?
    Diaz GA
    Immunol Rev; 2005 Feb; 203():235-43. PubMed ID: 15661033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
    Gustavsson M; Dyer DP; Zhao C; Handel TM
    Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines.
    Hanes MS; Salanga CL; Chowdry AB; Comerford I; McColl SR; Kufareva I; Handel TM
    J Biol Chem; 2015 Sep; 290(37):22385-97. PubMed ID: 26216880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 production.
    Antonello P; Pizzagalli DU; Foglierini M; Melgrati S; Radice E; Thelen S; Thelen M
    Front Immunol; 2022; 13():1067885. PubMed ID: 36713377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4
    Zmajkovicova K; Pawar S; Maier-Munsa S; Maierhofer B; Wiest I; Skerlj R; Taveras AG; Badarau A
    Genes Immun; 2022 Sep; 23(6):196-204. PubMed ID: 36089616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a chimeric chemokine as a specific ligand for ACKR3.
    Ameti R; Melgrati S; Radice E; Cameroni E; Hub E; Thelen S; Rot A; Thelen M
    J Leukoc Biol; 2018 Aug; 104(2):391-400. PubMed ID: 29601107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.